An invisible cause of disability: Stigma in migraine and epilepsy

Basit Öğe Kaydı
dc.authorid0000-0002-4104-8508
dc.contributor.authorBaşoğlu Köseahmet, Fulya
dc.contributor.authorPolat, Burcu
dc.contributor.authorGözübatık Çelik, Rabia Gökçen
dc.contributor.authorBaytekin, Işıl
dc.contributor.authorSoylu, Muazzez Gökçen
dc.contributor.authorDirican, ?Ayten Ceyhan
dc.contributor.authorÖztürk, Musa
dc.date.accessioned2022-11-15T07:10:00Z
dc.date.available2022-11-15T07:10:00Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı
dc.description.abstractObjective Our purpose was to identify the ratio and severity of stigmatization in patients with migraine and epilepsy. We also collected demographic and clinical data to search for possible facilitators. Methods In total, 196 patients with migraine and 60 patients with epilepsy were enrolled. Neuro-QoL Stigma Scale was applied in an office setting by a neurologist in 3 different centers. Stigma scores were calculated as standardized T scores (total, enacted, and internalized). Demographics, clinical characteristics, and treatment status of the patients were also compared in terms of stigma scores. Kruskal-Wallis test or Mann-Whitney U tests were applied for comparisons. Spearman's correlation analysis was used for the evaluation of inter-parameter correlations. Results Eighty-one percent of the patients with epilepsy and 72% of the patients with migraine reported being stigmatized. Total T scores were significantly higher in the epilepsy group (50.78 +/- 9.1) than the patients with migraine (44.9 +/- 7.62), also than the chronic (45.86 +/- 8.76) and episodic (44.7 +/- 7.27) migraine subgroups (p < 0.05). T scores increased as the duration of disease increased; however, this correlation was significant for the epilepsy group only (p < 0.05). Migraine group with prophylactic treatment had significantly higher scores than the migraineurs without preventive therapy (p < 0.05). Enacted T scores were higher than internalized T scores in all analyzed groups and subgroups (p < 0.05). Conclusion Patients with migraine and epilepsy are subjected to stigma. The ratio and intensity can change in different countries. We need to increase the awareness and search for better solutions. The standardized tests are important to compare results between studies.
dc.identifier.citationBaşoğlu Köseahmet, F., Polat, B., Gözübatık Çelik, R. G., Baytekin, I., Soylu, M. G., Dirican, ?A. C. ... Öztürk, M. (2022). An invisible cause of disability: Stigma in migraine and epilepsy. Neurological Sciences, 43(6), 3831-3838. https://doi.org/10.1007/s10072-022-05888-1
dc.identifier.doi10.1007/s10072-022-05888-1
dc.identifier.endpage3838
dc.identifier.issn1590-1874
dc.identifier.issn1590-3478
dc.identifier.issue6
dc.identifier.pmid35034235
dc.identifier.scopus2-s2.0-85123184354
dc.identifier.scopusqualityQ1
dc.identifier.startpage3831
dc.identifier.urihttps://doi.org/10.1007/s10072-022-05888-1
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9960
dc.identifier.volume43
dc.identifier.wos000742792300001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorPolat, Burcu
dc.language.isoen
dc.publisherSpringer - Verlag Italia Srl
dc.relation.ispartofNeurological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEpilepsy
dc.subjectMigraine
dc.subjectNeuro-QoL
dc.subjectStigma
dc.titleAn invisible cause of disability: Stigma in migraine and epilepsy
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu